Insulin
20 drugs across 3 manufacturers|0 Generic,20 Brand
The Insulin class contains 20 NDCs from 3 manufacturers (0 generic, 20 brand), at an average NADAC of $15.54 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
20
0G / 20B
Manufacturers
3
Avg $15.5418/unit
Avg 7d Change
+0.05%
Across 12 drugs with changes
7d Activity
of 20 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
3 manufacturers producing drugs in this therapeutic class
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Novo Nordisk manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Human Insulin market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Insulin class?
The Insulin class contains 20 NDCs from 3 manufacturers — 0 generic and 20 brand products.
What is the average price of Insulin drugs?
The average NADAC for the Insulin class is $15.5418 per unit across 20 NDCs.
Which manufacturers make Insulin drugs?
3 manufacturers make drugs in the Insulin class. Ranked by number of NDCs, the largest are Novo Nordisk (9), Eli Lilly and Company (8), Mannkind Corporation (3).
How has Insulin pricing changed recently?
Over the past 7 days, 5 NDCs in this class rose and 7 fell, with a class-wide average change of +0.1%.